Patents by Inventor Debedranath Dey

Debedranath Dey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds for treatment of inflammation, diabetes and related disorders
    Publication number: 20080188654
    Abstract: Novel acyl urea, thiourea, carbamate, thiocarbamate and related compounds are provided which are effective in inhibiting the cytokine-mediated inflammatory response in cultured cells, in ameliorating bone destruction in an animal model of arthritis and in lowering blood glucose levels in animal models of Type II diabetes mellitus. The compounds are disclosed as useful for a variety of treatments including the treatment of diabetes mellitus, insulin resistance, inflammation, inflammatory, diseases, immunological diseases and cancer.
    Type: Application
    Filed: December 20, 2007
    Publication date: August 7, 2008
    Applicant: Theracos, Inc.
    Inventors: Partha Neogi, Debedranath Dey, Joseph C. Fuller, Liang Chen, Ta-Kai Li
  • Compounds for treatment of inflammation, diabetes and related disorders
    Publication number: 20080108825
    Abstract: Novel acyl urea, thiourea, carbamate, thiocarbamate and related compounds are provided which are effective in inhibiting the cytokine-mediated inflammatory response in cultured cells, in ameliorating bone destruction in an animal model of arthritis and in lowering blood glucose levels in animal models of Type II diabetes mellitus. The compounds are disclosed as useful for a variety of treatments including the treatment of diabetes mellitus, insulin resistance, inflammation, inflammatory, diseases, immunological diseases and cancer.
    Type: Application
    Filed: December 20, 2007
    Publication date: May 8, 2008
    Applicant: Theracos, Inc.
    Inventors: Partha Neogi, Debedranath Dey, Joseph Fuller, Liang Chen, Ta-Kai Li
  • Compounds for treatment of inflammation, diabetes and related disorders
    Publication number: 20080103302
    Abstract: Novel acyl urea, thiourea, carbamate, thiocarbamate and related compounds are provided which are effective in inhibiting the cytokine-mediated inflammatory response in cultured cells, in ameliorating bone destruction in an animal model of arthritis and in lowering blood glucose levels in animal models of Type II diabetes mellitus. The compounds are disclosed as useful for a variety of treatments including the treatment of diabetes mellitus, insulin resistance, inflammation, inflammatory, diseases, immunological diseases and cancer.
    Type: Application
    Filed: December 20, 2007
    Publication date: May 1, 2008
    Applicant: Theracos, Inc.
    Inventors: Partha Neogi, Debedranath Dey, Joseph Fuller, Liang Chen, Ta-Kai Li
  • Compounds for treatment of inflammation, diabetes and related disorders
    Patent number: 7323496
    Abstract: Novel acyl urea, thiourea, carbamate, thiocarbamate and related compounds are provided which are effective in inhibiting the cytokine-mediated inflammatory response in cultured cells, in ameliorating bone destruction in an animal model of arthritis and in lowering blood glucose levels in animal models of Type II diabetes mellitus. The compounds are disclosed as useful for a variety of treatments including the treatment of diabetes mellitus, insulin resistance, inflammation, inflammatory diseases, immunological diseases and cancer.
    Type: Grant
    Filed: May 7, 2003
    Date of Patent: January 29, 2008
    Assignee: Theracos, Inc.
    Inventors: Partha Neogi, Debedranath Dey, Joseph Fuller, Liang Chen, Ta-Kai Li
  • COMPOUNDS FOR TREATMENT OF INFLAMMATION, DIABETES AND RELATED DISORDERS
    Publication number: 20070259961
    Abstract: Novel acyl urea, thiourea, carbamate, thiocarbamate and related compounds are provided which are effective in inhibiting the cytokine-mediated inflammatory response in cultured cells, in ameliorating bone destruction in an animal model of arthritis and in lowering blood glucose levels in animal models of Type II diabetes mellitus. The compounds are disclosed as useful for a variety of treatments including the treatment of diabetes mellitus, insulin resistance, inflammation, inflammatory diseases, immunological diseases and cancer.
    Type: Application
    Filed: May 7, 2003
    Publication date: November 8, 2007
    Inventors: Partha Neogi, Debedranath Dey, Joseph Fuller, Liang Chen, Ta-Kai Li
  • Compounds for treatment of inflammation, diabetes and related disorders
    Publication number: 20040097593
    Abstract: Novel acyl urea, thiourea, carbamate, thiocarbamate and related compounds are provided which are effective in inhibiting the cytokine-mediated inflammatory response in cultured cells, in ameliorating bone destruction in an animal model of arthritis and in lowering blood glucose levels in animal models of Type II diabetes mellitus. The compounds are disclosed as useful for a variety of treatments including the treatment of diabetes mellitus, insulin resistance, inflammation, inflammatory diseases, immunological diseases and cancer.
    Type: Application
    Filed: May 7, 2003
    Publication date: May 20, 2004
    Inventors: Partha Neogi, Debedranath Dey, Joseph C. Fuller, Liang Chen, Ta-Kai Li